logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

PRU (02378) spent 3.0226 million on August 3 to repurchase 271,800 shares.

date
17:07 04/08/2026
avatar
GMT Eight
Prudential (02378) announced that on August 3, 2026, it spent 3.0226 million to repurchase 271,800 shares; 270,700 shares of the repurchased stock were canceled.
PRU (02378) announced that it will spend 3.0226 million to repurchase 271,800 shares on August 3, 2026; and cancel 270,700 shares that have been repurchased.
Related Articles
HK Stock
TIMES CHINA (01233) recorded a cumulative contract sales amount of approximately 2.032 billion yuan in the first seven months, a year-on-year decrease of 36.54%.
HK Stock
CSPC PHARMA (01093): The new drug applications for Anritokizumab (KN026) and injectable docetaxel (albumin-bound) (HB1801) for neoadjuvant treatment have been accepted by the National Medical Products Administration.
China Stock
Jchx Mining Management (603979.SH) subsidiary signs $115 million mining contract.
TIMES CHINA (01233) recorded a cumulative contract sales amount of approximately 2.032 billion yuan in the first seven months, a year-on-year decrease of 36.54%.
HK Stock
CSPC PHARMA (01093): The new drug applications for Anritokizumab (KN026) and injectable docetaxel (albumin-bound) (HB1801) for neoadjuvant treatment have been accepted by the National Medical Products Administration.
HK Stock
Jchx Mining Management (603979.SH) subsidiary signs $115 million mining contract.
China Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.